Avilamycin is an antibiotic complex produced by cultures of the organism Streptomyces viridochromogenes, strain NRRL 2860. These compounds belong to the orthosomycin family of antibiotics. Structural composition of the major avilamycins and several minor avilamycins are known. Nine additional minor avilamycins, designated F through N, have been isolated via semi-preparative silica gel or reverse-phase high performance liquid chromatography with final purification using a reverse-phase column loading solvent switching technique. 1H NMR and mass spectroscopy, negative ion fast atom bombardment (neg FAB) and electron impact, were used to structurally identify the avilamycins.
H FT-NMR spectra of the avilamycins
were recorded on a Bruker WM-250 spectrometer at 250 MHz. The samples, 600~1,400 jig, were dissolved in 0.5 ml of acetone-d6 solvent and run at ambient temperature ('23°C) with internal TMS as reference. Difference NOE (nuclear Overhauser effect) spectra were obtained by subtracting free induction decays accumulated with the decoupler off-resonance from similar accumulations with particular resonances irradiated, followed by
Fourier transformation of the difference signals.
Mass Spectroscopy Studies
A VG Instrument, model ZAB-3F, was used to obtain negative ion fast atom bombardment (neg FAB) data. Avilamycins F, G and H were dissolved in thioglycerol and I, J, K, L, M and N were dissolved in 5 parts dithiothreitol and one part dithioerythritol, prior to analysis.
A Hewlett Packard 5985 GC-MS system with a direct insertion probe was used to obtain El (electron impact) spectra. Thermal desorption of the sample was achieved prior to the maximum probe temperature of 200°C.
+ Present address:
Uniroyal Chemical, Naugatuck, CT, 06770, U.S.A. The avilamycins were isolated from an avilamycin standard. The standard was prepared by extraction of the dried fermentation mycelia with acetone followed by decolorization and the addition of water to form crystals of avilamycin. The crystals were filtered and processed through a second acetonitrile -water re-crystallization then filtered and dried (personal communication, J. M.
EDMUNDOWICZ, Eli Lilly and Co.). The initial fractionation of the avilamycin was accomplished by normal or reverse-phase chromatography. Partial resolution of the avilamycins was achieved by loading 100' 500 mg of the standard in 3 % 2-propanol in chloroform onto a semi-preparative Woelm silica gel, 32-63 Fpm, column (11 mm x 100 cm). The column was developed at a flow rate 9 ml/ minute with 600 ml of 3 % 2-propanol in chloroform followed by 900 ml of 10 % 2-propanol in chloroform. Alternatively a semi-preparative Michel-Miller column (37 mm x 35 cm), ACE Glass Incorporated, packed with C-18 column material, carbon content 21 %, was used to obtain partial resolution of the avilamycins. About 250 mg of the standard was loaded onto the column in 55 % methanol in 0.04 M (NH4)2HPO4pH 7.0 buffer. A step gradient of 55, 60 and 62%. methanol in buffer was used to fractionate the avilamycins.
Final purification was accomplished by loading 100 -200 ml of the sample, dissolved in 30% methanol in pH 7.0 buffer, with a M45 pump onto a semi-preparative 10.6 x 250 mm IBM C-18 column.
Using a pump switching technique, through a Rheodyne 7120 injection valve, the avilamycins were resolved with a 50' 75 % methanol gradient in pH 7.0 buffer developed by a 1084B Hewlett Packard HPLC system.
The eluted avilamycins were monitored at a wavelength of 286 nm. Eluates containing the desired avilamycins were collected, diluted in pH 7.0 buffer and reloaded onto the semi-preparative a Fragmentation pattern of avilamycin breaking at each ring (Fig . 5) ; H is the deprotonated molecular weight (M-H)-, G is the deprotonated molecular weight of rings A through G. b Fragmentation pattern including A through G and part of ring H (see Fig . 5 ). 
Results and Conclusions
Structural identification of the avilamycins was aided by comparing the neg FAB mass spectral fragmentation data and the 1H NMR data to the data for avilamycin A and other known avilamycins.
See Tables I and 2 . Structural changes in the dichloroisoeverninic acid ring (A), predicted by the neg FAB mass spectrum, were verified by the EI mass spectrum. Fig. I shows the 250 MHz 1H NMR spectrum of avilamycin. Key assignments used can be found in Table 2 for avilamycin A.
The structurally unknown avilamycins F through N were designated via the sequence of their isolation and identification, which along with the known avilamycins A, B, C, D1 and E are shown in the HPLC of avilamycin standard 293-1 M6-155 (Fig. 2) . Avilamycins F, G and H were first separated from the other avilamycins using silica gel chromatography.
They were then purified by the reversephase HPLC solvent switching technique. Avilamycins I and J were first fractionated using the semipreparative C-18 column and were then purified via the column/solvent switching technique. Avilamycins K, L, M and N were isolated by loading about 300 mg of the standard onto the semi-analytical IBM column and were then resolved via the gradient elution-solvent switching technique.
Avilamycin A
The structure of avilamycin A is shown in Fig. 3 . The 1H NMR data ( The molecular ion region of the neg FAB spectrum of avilamycin A is shown in Fig. 4 showed a consistent decrease of 48 mass units throughout the ring fragmentation pattern which suggested the decrease in molecular weight was in the A ring.
1 H NMR spectral data of F, Table 2 , showed the absence of the methoxy functional group at 3.88 ppm (C-7) on the A ring. The retention of the aromatic methyl (C-8) on the A ring was confirmed by the singlet signal at 2.48 ppm. An aromatic proton resonance (ringlet) was found at 6.50 ppm indicating the presence of a proton on A ring at either C-2 or C-6. 1H NMR NOE studies suggested that the chlorine was present at C-6 with a proton at C-2 (see Results for H). An El mass spectrum was run to by neg FAB mass spectroscopy. The additional 14 amu suggested the addition of a CH2 group to an avilamycin like structure. Examination of the neg FAB fragmentation data of avilamycins A and G, Table 1 and Fig. 5 , showed identical fragmentation patterns of A through the F rings for both compounds. Data including the G and G+H rings were m/z 14 units higher for avilamycin G, 1,183 versus 1,169 and 1,243 versus 1,229, when compared to avilamycin A. These data indicated that the CH2 addition was at the R1ester linkage to ring G. (Table 2) , showed both compounds were similar but with differences in the A ring. 1H NMR NOE studies were run to determine the structure of the dechloro compound. Irradiation of the OCH3 (C-7) followed by subtraction of the normal spectrum (NOE difference) did not give a signal intensity enhancement of the aromatic proton, which suggested the chlorine was still present at C-2. Correspondingly, irradiation of the CH3(C-8) followed
by subtraction of the normal spectrum gave a positive intensity enhancement at 6.71 ppm. These data confirmed the replacement of the chlorine at C-6 with a proton.
Avilamycin I 1H NMR spectral data of I (Table 2) (Table 1 ). All fragmentation data for avilamycin J when compared to avilamycin A was 14 amu less from F through the H rings. These data suggested the loss of a CH2 at C-41 or C-43 (see Fig. 3 ) of the F ring. 1H NMR spectral data of J confirmed the presence of three of the four methoxy groups , singlets (Table 1) showed both compounds were identical to avilamycin A in rings A through D. At E ring, two sets of fragmentation data appeared, one fragment was similar to avilamycin A and the second fragment was 14 amu less or a loss of CH2 at the E ring. However at the E ring, for both fractions, two sets of fragmentation data appeared, one similar to A and other fragment 14 amu less indicating the loss of a CH, group.
At F ring the fragmentation data were identical (M-H)-=986 for both fractions, indicating the loss of CH2., from compound No. 3 or avilamycin N. The fragmentation patterns for both compounds were identical in rings G and H which gave a net loss of CH, for both compounds when compared to avilamycin A (Table 1) .
1 H NMR spectra for both fractions are summarized in Table 2 . The loss of a CH2 in ring E to form avilamycin M can occur at one of two carbon positions, C-34 or C-35. The 1H NMR response at 3.52 ppm in both fractions indicates the presence of C-34 methoxy functional group in avilamycin M.
Since two compounds are present in both fractions, with and without the methyl group at C-35, one would expect a shift in the C-34 methoxy functional group response for each compound. Such a doublet does exist in the second fraction at 3.52 and 3.53 ppm for the C-34 methoxy group.
The loss of a CH, in the F ring to form avilamycin N can occur only at C-41 or C-43. Diminished (fraction No. 2) or absent (fraction No. 3) is the methoxy functional group (3.56 -3.58) at C-41 which indicated the loss of the CH2 from the methoxy group attached at C-41 on the ring. Correspondingly, in both fractions the presence of the methoxy group at C-43 was indicated by the strong signal at 3.29 ppm in both fractions. Signals of equal intensity for both compounds were also observed for the aryl methoxy functional group (C-7) at 3.87 ppm. The structure assignments for all avilamycins are shown in Fig. 7 . 
